PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33120845-13	2020	LESSONS: APL patients with STAT5B-RARa is not only resistant to ATRA, but also to conventional combination chemotherapy such as daunorubicin and cytarabine/idarubicin and cytarabine or other regimens.	Idarubicin	156-166	retinoic acid receptor alpha	Homo sapiens	34-38	
9242531-0	1997	Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy.	Idarubicin	115-125	retinoic acid receptor alpha	Homo sapiens	27-36